While glucose tolerance and insulin sensitivity remained unchanged, combination therapy restored insulin secretion, increased β-cell mass, and reduced apoptosis, suggesting a protective role in type 2 diabetes treatment (22). Here, INS is linked to type 2 diabetes mellitus.